ARCHIVES

ImClone Offered C225 Deal To Seven Firms Prior To BMS

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

Cost of Care: Medicare Patients Charged More In Outpatient Care Settings

November 1, 2013

Cancer Trials Take 800 Days To Start On Average; NCI Vows Improvement.

April 11, 2008

Fy 1981 Budget Breakdown B Mechanism, Activity

February 1, 1980

NCI RFA: Tobacco Use Research Centers

December 18, 1998

New Frederick RFP Out May 14; Five contracts To Be Awarded, Each For Five to Seven Years

May 2, 1986